SABR ‘Quite Safe’ for Treating Oligometastases
Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.
Diagnosis & Disease Information
Bevacizumab Biosimilar Vegzelma Gets FDA Approval
Vegzelma is a vascular endothelial growth factor inhibitor.
Cancer Surgery Complications Are More Common in Dialysis Population
A study examined the rates of postoperative complications and death following surgery for colorectal, lung, gastric, and breast cancer.
- Loading...
Loading...
Next post in Hemodialysis
Loading... 
Loading...